SCHEMBL19862903

SCHEMBL19862903

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-n4c5ccccc5c5c(-c6ccc(-n7c8ccccc8c8ccccc87)cc6)cc6c7ccccc7oc6c54)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.34
KDM4E B2RXH2 4/20 0.33
TSHR P16473 4/20 0.33
ALDH1A1 P00352 4/20 0.33
LMNA P02545 4/20 0.33
HSD17B10 Q99714 2/20 0.33
POLB P06746 2/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
PTPN1 P18031 1/20 0.31
USP2 O75604 1/20 0.31
HTT P42858 1/20 0.31
HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594077 0.99 MAPT (0.34) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL19862895 0.95 MAPT (0.32) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL19863060 0.95 MAPT (0.36) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL19863001 0.94 KDM4E (0.33) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL19862998 0.94 KDM4E (0.33) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL18594352 0.94 MAPT (0.37) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL19862900 0.93 KDM4E (0.33) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL19862896 0.93 KDM4E (0.33) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL18594417 0.93 MAPT (0.38) MAPTKDM4ETSHRALDH1A1LMNA
SCHEMBL19862884 0.92 KDM4E (0.34) MAPTKDM4ETSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MAPT 746/4885KDM4E 1039/4885TSHR 3741/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAPT 746/4885KDM4E 1039/4885TSHR 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.